Literature DB >> 9251100

Sigma 1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain.

T Kobayashi1, K Matsuno, M Murai, S Mita.   

Abstract

Our previous studies have shown that three sigma (sigma) receptor ligands, (+)-N-allylnormetazocine ((+)-SKF-10,047), (+/-)-pentazocine and 1,3-di(2-tolyl)guanidine (DTG) differently regulated the dopamine (DA) transmission in the rat brain. In the present study, we attempted to clarify the role of sigma 1 receptor subtype in the regulation of DA transmission using a novel and selective sigma 1 receptor agonist, 1-(3,4-dimethoxyphenethyl)-4(3-phenylpropyl)piperazine dihydrochloride (SA4503) in the rat brain. Acute administration of SA4503 (1.0 mg/kg, p.o.) significantly increased DA and 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the rat frontal cortex, but not in the other six regions, hippocampus, striatum, midbrain, cerebellum, medulla/pons and hypothalamus. The increase of cortical DA level elicited by SA4503 was fully reversed by N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine (NE-100) (0.25 mg/kg, p.o.), a putative sigma 1 receptor antagonist. In addition, SA4503 (1.0 mg/kg, p.o.) showed an increase of cortical L-3,4-dihydroxyphenylalanine (L-DOPA) accumulation under the inhibition of dopa decarboxylase activity with m-hydrobenzylhydrazine (NSD-1015), suggesting that SA4503 has activated the cortical DA synthesis rate. These results suggest that the sigma 1 receptor subtype plays an important role in the facilitation of cortical DA transmission. In addition, this phenomenon is partially involved in the augmentation of DA synthesis rate.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9251100     DOI: 10.1023/a:1027361101419

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  32 in total

1.  Neuroleptic-sensitive binding sites in the nigrostriatal system: evidence for differential distribution of sigma sites in the substantia nigra, pars compacta of the cat.

Authors:  A M Graybiel; M J Besson; E Weber
Journal:  J Neurosci       Date:  1989-01       Impact factor: 6.167

2.  Autoradiographic distribution of non-dopaminergic binding sites labeled by [3H]haloperidol in rat brain.

Authors:  P C Contreras; R Quirion; D R Gehlert; M L Contreras; T L O'Donohue
Journal:  Neurosci Lett       Date:  1987-03-31       Impact factor: 3.046

3.  Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists.

Authors:  E T Iwamoto
Journal:  J Pharmacol Exp Ther       Date:  1981-05       Impact factor: 4.030

4.  Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.

Authors:  B L Largent; A L Gundlach; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1986-08       Impact factor: 4.030

5.  Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine.

Authors:  A L Gundlach; B L Largent; S H Snyder
Journal:  J Neurosci       Date:  1986-06       Impact factor: 6.167

6.  Binding properties of SA4503, a novel and selective sigma 1 receptor agonist.

Authors:  K Matsuno; M Nakazawa; K Okamoto; Y Kawashima; S Mita
Journal:  Eur J Pharmacol       Date:  1996-06-13       Impact factor: 4.432

Review 7.  Dopamine and depression: a review of recent evidence. I. Empirical studies.

Authors:  P Willner
Journal:  Brain Res       Date:  1983-12       Impact factor: 3.252

8.  Sigma-1 and sigma-2 sites in rat brain: comparison of regional, ontogenetic, and subcellular patterns.

Authors:  D J McCann; A D Weissman; T P Su
Journal:  Synapse       Date:  1994-07       Impact factor: 2.562

9.  NE-100, a novel sigma receptor ligand: in vivo tests.

Authors:  S Okuyama; Y Imagawa; S Ogawa; H Araki; A Ajima; M Tanaka; M Muramatsu; A Nakazato; K Yamaguchi; M Yoshida
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

10.  Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?

Authors:  G Tanda; E Carboni; R Frau; G Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

View more
  12 in total

Review 1.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

2.  Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficits.

Authors:  Ann N Hoffman; Jeffrey P Cheng; Ross D Zafonte; Anthony E Kline
Journal:  Life Sci       Date:  2008-08-31       Impact factor: 5.037

3.  Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized/castrated mice via both 5-HT reuptake inhibition and σ(1) receptor activation.

Authors:  Yukio Ago; Koji Yano; Naoki Hiramatsu; Kazuhiro Takuma; Toshio Matsuda
Journal:  Psychopharmacology (Berl)       Date:  2011-04-13       Impact factor: 4.530

4.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

Review 5.  The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.

Authors:  Danielle O Sambo; Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Pharmacol Ther       Date:  2018-01-31       Impact factor: 12.310

6.  Facilitated neurogenesis in the developing hippocampus after intake of theanine, an amino acid in tea leaves, and object recognition memory.

Authors:  Atsushi Takeda; Kazuhiro Sakamoto; Haruna Tamano; Kotaro Fukura; Naoto Inui; Sang Won Suh; Seok-Joon Won; Hidehiko Yokogoshi
Journal:  Cell Mol Neurobiol       Date:  2011-05-22       Impact factor: 5.046

7.  Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis.

Authors:  Linda Garcés-Ramírez; Jennifer L Green; Takato Hiranita; Theresa A Kopajtic; Maddalena Mereu; Alexandra M Thomas; Christophe Mesangeau; Sanju Narayanan; Christopher R McCurdy; Jonathan L Katz; Gianluigi Tanda
Journal:  Biol Psychiatry       Date:  2010-10-15       Impact factor: 13.382

Review 8.  New hypothesis and treatment targets of depression: an integrated view of key findings.

Authors:  Shangli Cai; Shucai Huang; Wei Hao
Journal:  Neurosci Bull       Date:  2015-01-09       Impact factor: 5.203

9.  A Role for Sigma Receptors in Stimulant Self Administration and Addiction.

Authors:  Jonathan L Katz; Tsung-Ping Su; Takato Hiranita; Teruo Hayashi; Gianluigi Tanda; Theresa Kopajtic; Shang-Yi Tsai
Journal:  Pharmaceuticals (Basel)       Date:  2011

10.  Sigma-1 Agonist Binding in the Aging Rat Brain: a MicroPET Study with [(11)C]SA4503.

Authors:  Nisha K Ramakrishnan; Anniek K D Visser; Anna A Rybczynska; Csaba J Nyakas; Paul G M Luiten; Chantal Kwizera; Jurgen W A Sijbesma; Philip H Elsinga; Kiichi Ishiwata; Rudi A J O Dierckx; Aren van Waarde
Journal:  Mol Imaging Biol       Date:  2016-08       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.